| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Loan facility liability | - | -2,000 |
| Net cash used in operating activities | -38,658 | -32,023 |
| Purchases of property and equipment | 7,506 | 4,638 |
| Net cash used in investing activities | -7,506 | -4,638 |
| Proceeds from issuance of common stock from the exercise of stock options | 3,249 | 2,171 |
| Proceeds from issuance of common stock under employee stock purchase plan | 3,504 | 3,505 |
| Net cash provided by financing activities | 6,753 | 5,676 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -33 | -23 |
| Net decrease in cash, cash equivalents and restricted cash | -39,444 | -31,008 |
| Cash and cash equivalents at beginning of period | 336,763 | - |
| Cash and cash equivalents at end of period | 297,319 | - |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)